Indoco Remedies Ltd
NSE:INDOCO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Indoco Remedies Ltd
NSE:INDOCO
|
IN |
|
Hovding Sverige AB (publ)
F:HS4
|
SE |
|
Manhattan Associates Inc
NASDAQ:MANH
|
US |
|
F
|
Fluidra SA
XBER:4F1
|
ES |
|
Heartland Express Inc
NASDAQ:HTLD
|
US |
|
UnUsUal Ltd
SGX:1D1
|
SG |
|
R
|
Reed's Inc
XBER:39R
|
US |
|
Sarimelati Kencana Tbk PT
IDX:PZZA
|
ID |
|
Item 9 Labs Corp
OTC:INLB
|
US |
|
Digital Brands Group Inc
NASDAQ:DBGI
|
US |
|
Emerita Resources Corp
XTSX:EMO
|
CA |
Wall Street
Price Targets
INDOCO Price Targets Summary
Indoco Remedies Ltd
According to Wall Street analysts, the average 1-year price target for
INDOCO
is 251.43 INR
with a low forecast of 224.22 INR and a high forecast of 288.75 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is INDOCO's stock price target?
Price Target
251.43
INR
According to Wall Street analysts, the average 1-year price target for
INDOCO
is 251.43 INR
with a low forecast of 224.22 INR and a high forecast of 288.75 INR.
What is Indoco Remedies Ltd's Revenue forecast?
Projected CAGR
12%
For the last 13 years the
compound annual growth rate for
Indoco Remedies Ltd's revenue is
9%.
The projected
CAGR
for the next 3 years is
12%.
